Article info
Colorectal
Research
Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease
- Correspondence to Dr James Turvill, Department of Gastroenterology, York Hospital, York Teaching Hospital NHS Foundation Trust, Wigginton Road, York YO31 8HE, UK; james.turvill{at}york.nhs.uk
Citation
Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's disease
Publication history
- Received November 17, 2016
- Revised January 9, 2017
- Accepted January 10, 2017
- First published January 30, 2017.
Online issue publication
June 05, 2017
Article Versions
- Previous version (30 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/